LUND, Sweden, May 17, 2023 /PRNewswire/ Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference
LUND, Sweden, May 6, 2023 /PRNewswire/ Philipp von Hugo, member of the board of directors of Immunovia AB (publ) ("Immunovia" or the "Company"), has at his own request notified his resignation
April 29, 2023, Lund, Sweden
LUND, SWEDEN - As a next step in focusing on the US market The Board of Directors of Immunovia AB , has today decided to appoint Jeff Borcherding, until. | April 29, 2023
LUND, Sweden, April 26, 2023 /PRNewswire/ Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first test dedicated to the early detection of pancreatic
LUND, Sweden, April 21, 2023 /PRNewswire/ Immunovia AB (publ) today announced that the Annual Report for 2022 has been published. The annual report can be downloaded in pdf format and